In a prospective study conducted in a diagnostic laboratory in Mexico City, luciferase reporter mycobacteriophages (LRPs) were evaluated for their utility and performance in identification and antibiotic-susceptibility testing of Mycobacterium tuberculosis complex (MTC) isolates from MGIT-960 cultures. Eighty-four consecutive MGIT cultures recovered from 54 patients were included in this study. The LRPs confirmed mycobacterial growth in 79 (94 %) of 84 MGIT cultures. Failure to confirm growth was due to low inoculum (n = 1) or growth with non-tuberculous mycobacteria (n = 4). The median time to confirmation of MGIT cultures was 1 day (range 1–55). Confirmed cultures were identified with p-nitro-α-acetylamino-β-hydroxypropiophenone (NAP), a selective inhibitor of MTC species, and results obtained with LRPs were compared with those obtained by BACTEC-460. The sensitivity and specificity of the LRP NAP test were respectively 97 and 100 %, and the median turnaround time for identification was 3 days with both methods. The accuracy and speed of the LRPs for susceptibility testing with rifampicin, streptomycin, isoniazid and ethambutol were compared with BACTEC-460 and discrepant results were tested by the conventional agar proportion method. In total, 72 MTC cultures were tested. The overall agreement between the LRPs and BACTEC-460 was 98.6 %. Four isolates (5.6 %) were falsely identified as ethambutol-resistant. The median turnaround time for susceptibility testing was 3 days (range 3–57) with the LRPs and 9 days (range 7–29) with BACTEC-460. LRPs offer an accurate and rapid approach for identification and susceptibility testing of M. tuberculosis from MGIT-960 cultures.
BecerraM. C,
FreemanJ,
BayonaJ.9 other authors2000; Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 4:108–114
EspinalM. A,
KimS. J,
SuarezP. G.7 other authors2000; Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 283:2537–2545[CrossRef]
GrossW. M,
HawkinsJ. E.1985; Radiometric selective inhibition tests for differentiation of Mycobacterium tuberculosis , Mycobacterium bovis , and other mycobacteria. J Clin Microbiol 21:565–568
HeifetsL. B,
CangelosiG. A.1999; Drug susceptibility testing of Mycobacterium tuberculosis : a neglected problem at the turn of the century. Int J Tuberc Lung Dis 3:564–581
JacobsW. RJr,
BarlettaR. G,
UdaniR.7 other authors1993; Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819–822[CrossRef]
Joint Tuberculosis Committee of the British Thoracic Society; 1998; Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 53:536–548[CrossRef]
LaszloA,
SiddiqiS. H.1984; Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p -nitro-α-acetylamino-β-hydroxypropiophenone. J Clin Microbiol 19:694–698
RiskaP. F,
JacobsW. RJr,
BloomB. R,
McKitrickJ,
ChanJ.1997; Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p -nitro-α-acetylamino-β-hydroxy propiophenone. J Clin Microbiol 35:3225–3231
Rüsch-GerdesS,
DomehlC,
NardiG,
GismondoM. R,
WelscherH. M,
PfyfferG. E.1999; Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol 37:45–48
TenoverF. C,
CrawfordJ. T,
HuebnerR. E,
GeiterL. J,
HorsburghC. RJr,
GoodR. C.1993; The resurgence of tuberculosis: is your laboratory ready?. J Clin Microbiol 31:767–770
TimmeT. L,
BrennanP. J.1984; Induction of bacteriophage from members of the Mycobacterium avium , Mycobacterium intracellulare , Mycobacterium scrofulaceum serocomplex. J Gen Microbiol 130:2059–2066